CS logo
small CS logo
Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde

Munchen, Germany
Frauenklinik in München, Bayern

About Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Pfizer
3
Technical University of Munich
3
Total Rows: 3

Clinical Trials at Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde


During the past decade, Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11001100000011222222221111111100Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
2007-07-01
2014-09-01
Completed
223
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
2008-09-15
2017-12-20
Completed
177
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Federal Joint Committee" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde


According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde" are "Breast Cancer" (5 trials), "Breast Neoplasms" (2 trials), "Ovarian Cancer" (2 trials), "Advanced Breast Cancer" (1 trials) and "Advanced Gastric Cancer" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde


Most popular intervention types in "Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde" are "Drug" (11 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pertuzumab" (5 trials), "Paclitaxel" (4 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde


The vast majority of trials in "Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde" are 8 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde


Currently, there are NaN active trials in "Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status